Status:
RECRUITING
Prilocaine for Sphenopalatine Ganglion Block in Endoscopic Hypophysectomy
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Blood Pressure Control
Eligibility:
All Genders
21-45 years
Phase:
NA
Brief Summary
Patients undergoing endoscopic surgeries for pituitary adenoma excision suffer from wide swings in blood pressure that might increase bleeding and interfere with the surgical field. Local anethetic i...
Detailed Description
Pituitary adenoma excision through endoscopic sinus surgery has been evolving over the years. Though less traumatic less traumatic and less invasive than other approaches, hemodynamic variations durin...
Eligibility Criteria
Inclusion
- Patients with pituitary adenoma undergoing endoscopic hypophysectomy.
- ASA physical status I and II.
- Age above 21, below 45 years.
- Male or female
Exclusion
- Any patient below 21 years or above 45 years.
- Patients suffering from any of the following conditions:
- Disturbed conscious level.
- Coagulation abnormalities.
- Poorly controlled blood pressure and/or heart rate.
- Increased intracranial tension.
- Liver and kidney disorders.
- Patients on anticoagulants and/or NSAIDS (non-steroidal anti- inflammatory drugs
- Patients addicted to drugs and/or alcohol.
- Patients with disturbed conscious level at the end of the surgery, GCS \>14
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT07188987
Start Date
December 1 2025
End Date
February 1 2026
Last Update
December 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr El Ainy
Cairo, Egypt, 11956